Polycystic Kidney Disease Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Polycystic Kidney Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polycystic Kidney Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polycystic Kidney Disease Treatment Overall Market Size
2.1 Global Polycystic Kidney Disease Treatment Market Size: 2021 VS 2028
2.2 Global Polycystic Kidney Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Polycystic Kidney Disease Treatment Players in Global Market
3.2 Top Global Polycystic Kidney Disease Treatment Companies Ranked by Revenue
3.3 Global Polycystic Kidney Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Polycystic Kidney Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Polycystic Kidney Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Polycystic Kidney Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Polycystic Kidney Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 ANG-3070
4.1.3 CIM-2
4.1.4 CR-8
4.1.5 Others
4.2 By Type - Global Polycystic Kidney Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Polycystic Kidney Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Polycystic Kidney Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Polycystic Kidney Disease Treatment Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Research Center
5.1.4 Hospital
5.2 By Application - Global Polycystic Kidney Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Polycystic Kidney Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Polycystic Kidney Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Polycystic Kidney Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Polycystic Kidney Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Polycystic Kidney Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Polycystic Kidney Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Polycystic Kidney Disease Treatment Revenue, 2017-2028
6.3.2 US Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.3.3 Canada Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.3.4 Mexico Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Polycystic Kidney Disease Treatment Revenue, 2017-2028
6.4.2 Germany Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4.3 France Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4.4 U.K. Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4.5 Italy Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4.6 Russia Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.4.8 Benelux Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Polycystic Kidney Disease Treatment Revenue, 2017-2028
6.5.2 China Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.5.3 Japan Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.5.4 South Korea Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.5.6 India Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Polycystic Kidney Disease Treatment Revenue, 2017-2028
6.6.2 Brazil Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.6.3 Argentina Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Polycystic Kidney Disease Treatment Revenue, 2017-2028
6.7.2 Turkey Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.7.3 Israel Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Polycystic Kidney Disease Treatment Market Size, 2017-2028
6.7.5 UAE Polycystic Kidney Disease Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Angion Biomedica Corp
7.1.1 Angion Biomedica Corp Corporate Summary
7.1.2 Angion Biomedica Corp Business Overview
7.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Major Product Offerings
7.1.4 Angion Biomedica Corp Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.1.5 Angion Biomedica Corp Key News
7.2 Aptevo Therapeutics Inc
7.2.1 Aptevo Therapeutics Inc Corporate Summary
7.2.2 Aptevo Therapeutics Inc Business Overview
7.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.2.4 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.2.5 Aptevo Therapeutics Inc Key News
7.3 Celgene Corp
7.3.1 Celgene Corp Corporate Summary
7.3.2 Celgene Corp Business Overview
7.3.3 Celgene Corp Polycystic Kidney Disease Treatment Major Product Offerings
7.3.4 Celgene Corp Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.3.5 Celgene Corp Key News
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Corporate Summary
7.4.2 Conatus Pharmaceuticals Inc Business Overview
7.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.4.4 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.4.5 Conatus Pharmaceuticals Inc Key News
7.5 DiscoveryBiomed Inc
7.5.1 DiscoveryBiomed Inc Corporate Summary
7.5.2 DiscoveryBiomed Inc Business Overview
7.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.5.4 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.5.5 DiscoveryBiomed Inc Key News
7.6 Endocyte Inc
7.6.1 Endocyte Inc Corporate Summary
7.6.2 Endocyte Inc Business Overview
7.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.6.4 Endocyte Inc Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.6.5 Endocyte Inc Key News
7.7 IC-MedTech Inc
7.7.1 IC-MedTech Inc Corporate Summary
7.7.2 IC-MedTech Inc Business Overview
7.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.7.4 IC-MedTech Inc Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.7.5 IC-MedTech Inc Key News
7.8 Ipsen SA
7.8.1 Ipsen SA Corporate Summary
7.8.2 Ipsen SA Business Overview
7.8.3 Ipsen SA Polycystic Kidney Disease Treatment Major Product Offerings
7.8.4 Ipsen SA Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.8.5 Ipsen SA Key News
7.9 Kadmon Corp LLC
7.9.1 Kadmon Corp LLC Corporate Summary
7.9.2 Kadmon Corp LLC Business Overview
7.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Major Product Offerings
7.9.4 Kadmon Corp LLC Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.9.5 Kadmon Corp LLC Key News
7.10 Madrigal Pharmaceuticals Inc.
7.10.1 Madrigal Pharmaceuticals Inc. Corporate Summary
7.10.2 Madrigal Pharmaceuticals Inc. Business Overview
7.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Major Product Offerings
7.10.4 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.10.5 Madrigal Pharmaceuticals Inc. Key News
7.11 ManRos Therapeutics
7.11.1 ManRos Therapeutics Corporate Summary
7.11.2 ManRos Therapeutics Business Overview
7.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Major Product Offerings
7.11.4 ManRos Therapeutics Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.11.5 ManRos Therapeutics Key News
7.12 Metabolic Solutions Development Company LLC
7.12.1 Metabolic Solutions Development Company LLC Corporate Summary
7.12.2 Metabolic Solutions Development Company LLC Business Overview
7.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Major Product Offerings
7.12.4 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.12.5 Metabolic Solutions Development Company LLC Key News
7.13 Mironid Ltd
7.13.1 Mironid Ltd Corporate Summary
7.13.2 Mironid Ltd Business Overview
7.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Major Product Offerings
7.13.4 Mironid Ltd Polycystic Kidney Disease Treatment Revenue in Global Market (2017-2022)
7.13.5 Mironid Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Polycystic Kidney Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Polycystic Kidney Disease Treatment Market Drivers in Global Market
Table 3. Polycystic Kidney Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Polycystic Kidney Disease Treatment in Global Market
Table 5. Top Polycystic Kidney Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Polycystic Kidney Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Polycystic Kidney Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Polycystic Kidney Disease Treatment Product Type
Table 9. List of Global Tier 1 Polycystic Kidney Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Polycystic Kidney Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Polycystic Kidney Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Polycystic Kidney Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Polycystic Kidney Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Polycystic Kidney Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Polycystic Kidney Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Angion Biomedica Corp Corporate Summary
Table 31. Angion Biomedica Corp Polycystic Kidney Disease Treatment Product Offerings
Table 32. Angion Biomedica Corp Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Aptevo Therapeutics Inc Corporate Summary
Table 34. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Product Offerings
Table 35. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Celgene Corp Corporate Summary
Table 37. Celgene Corp Polycystic Kidney Disease Treatment Product Offerings
Table 38. Celgene Corp Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Conatus Pharmaceuticals Inc Corporate Summary
Table 40. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Product Offerings
Table 41. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. DiscoveryBiomed Inc Corporate Summary
Table 43. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Product Offerings
Table 44. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Endocyte Inc Corporate Summary
Table 46. Endocyte Inc Polycystic Kidney Disease Treatment Product Offerings
Table 47. Endocyte Inc Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. IC-MedTech Inc Corporate Summary
Table 49. IC-MedTech Inc Polycystic Kidney Disease Treatment Product Offerings
Table 50. IC-MedTech Inc Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Ipsen SA Corporate Summary
Table 52. Ipsen SA Polycystic Kidney Disease Treatment Product Offerings
Table 53. Ipsen SA Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Kadmon Corp LLC Corporate Summary
Table 55. Kadmon Corp LLC Polycystic Kidney Disease Treatment Product Offerings
Table 56. Kadmon Corp LLC Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Madrigal Pharmaceuticals Inc. Corporate Summary
Table 58. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Product Offerings
Table 59. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. ManRos Therapeutics Corporate Summary
Table 61. ManRos Therapeutics Polycystic Kidney Disease Treatment Product Offerings
Table 62. ManRos Therapeutics Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Metabolic Solutions Development Company LLC Corporate Summary
Table 64. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Product Offerings
Table 65. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Mironid Ltd Corporate Summary
Table 67. Mironid Ltd Polycystic Kidney Disease Treatment Product Offerings
Table 68. Mironid Ltd Polycystic Kidney Disease Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Polycystic Kidney Disease Treatment Segment by Type in 2021
Figure 2. Polycystic Kidney Disease Treatment Segment by Application in 2021
Figure 3. Global Polycystic Kidney Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Polycystic Kidney Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Polycystic Kidney Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2021
Figure 8. By Type - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Polycystic Kidney Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Polycystic Kidney Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Angion Biomedica Corp Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celgene Corp Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Endocyte Inc Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. IC-MedTech Inc Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ipsen SA Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Kadmon Corp LLC Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ManRos Therapeutics Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Mironid Ltd Polycystic Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
